TRAMADOL HYDROCHLORIDE (tramadol hydrochloride) by Fosun Pharma is mechanism of action tramadol hydrochloride extended release tablet is a centrally acting synthetic opioid analgesic. Approved for moderate to moderately severe chronic pain in adults. First approved in 2011.
Drug data last refreshed 19h ago
Mechanism of Action Tramadol hydrochloride extended release tablet is a centrally acting synthetic opioid analgesic. Although its mode of action is not completely understood, from animal tests, at least two complementary mechanisms appear applicable: binding of parent and M1 metabolite to µ-opioid…
Worked on TRAMADOL HYDROCHLORIDE at Fosun Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back Pain
Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets
Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers